Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface extracellular matrix (ECM) receptors are a diverse group of transmembrane proteins that mediate the attachment of cells to the surrounding extracellular environment and translate mechanical and chemical cues into intracellular signals. The most prominent members of this group are the integrins, but it also includes non-integrin receptors such as syndecans, discoidin domain receptors (DDRs), and CD44. These receptors play critical roles in maintaining tissue architecture, regulating cell survival, and directing migration during development and wound healing. In pathological states, dysregulation of ECM receptors is a hallmark of cancer progression, where they facilitate tumor cell invasion and metastasis, as well as fibrotic diseases characterized by excessive matrix deposition. Therapeutic strategies targeting these receptors often involve monoclonal antibodies or small molecules designed to block ligand binding or inhibit downstream signaling cascades.
Antagonism of ligand binding (e.g., blocking fibrinogen or VCAM-1 binding), modulation of intracellular signaling pathways (outside-in signaling), and inhibition of cell-matrix adhesion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface extracellular matrix receptor (ECM receptor).